Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice

Transfusion

Volumn 53, Issue 11, 2013, Pages 2697-2709

  Jackman, Rachael P ^a   Muench, Marcus O ^a   Heitman, John W ^a   Inglis, Heather C ^a   Law, Jacqueline P ^a   Marschner, Susanne ^a   Goodrich, Raymond P ^a   Norris, Philip J ^a  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ALLOANTIGEN; CELL ADHESION MOLECULE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; MONOCYTE CHEMOTACTIC PROTEIN 1; RIBOFLAVIN; TUMOR NECROSIS FACTOR ALPHA;

ALLOIMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; CYTOKINE RESPONSE; EX VIVO STUDY; FEMALE; IMMUNOGENICITY; IMMUNOMODULATION; IN VIVO STUDY; LEUKOCYTE; MOUSE; NONHUMAN; SPLEEN CELL; THROMBOCYTE RICH PLASMA; THROMBOCYTE TRANSFUSION; ULTRAVIOLET B RADIATION;

ANIMALS; BLOOD PLATELETS; CYTOKINES; FEMALE; ISOANTIBODIES; ISOANTIGENS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PLATELET TRANSFUSION; RIBOFLAVIN; ULTRAVIOLET RAYS;

EID: 84887826176     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12133     Document Type: Article

References (31)

1. Akahoshi M, Takanashi M, Masuda M, Yamashita H, Hidano A, Hasegawa K, Kasajima T, Shimizu M, Motoji T, Oshimi K, Mizoguchi H,. A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filters. Transfusion 1992; 32: 169-172.
2. Williamson LM, Stainsby D, Jones H, Love E, Chapman CE, Navarrete C, Lucas G, Beatty C, Casbard A, Cohen H,. The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease. Transfusion 2007; 47: 1455-1467.
3. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997; 337: 1861-1869.
4. Slichter SJ, Davis K, Enright H, Braine H, Gernsheimer T, Kao KJ, Kickler T, Lee E, McFarland J, McCullough J, Rodey G, Schiffer CA, Woodson R,. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005; 105: 4106-4114.
5. Blundell EL, Pamphilon DH, Fraser ID, Menitove JE, Greenwalt TJ, Snyder EL, Repucci AJ, Hedberg SL, Anderson JK, Buchholz DH, Kagen LR, Aster RH,. A prospective, randomized study of the use of platelet concentrates irradiated with ultraviolet-B light in patients with hematologic malignancy. Transfusion 1996; 36: 296-302.
6. Jackman RP, Heitman JW, Marschner S, Goodrich RP, Norris PJ,. Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment. Transfusion 2009; 49: 2686-2699.
7. Luban NL, Drothler D, Moroff G, Quinones R,. Irradiation of platelet components: inhibition of lymphocyte proliferation assessed by limiting-dilution analysis. Transfusion 2000; 40: 348-352.
8. Pelszynski MM, Moroff G, Luban NL, Taylor BJ, Quinones RR,. Effect of gamma irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: implications for preventing transfusion-associated graft-versus-host disease. Blood 1994; 83: 1683-1689.
9. Cardo LJ, Rentas FJ, Ketchum L, Salata J, Harman R, Melvin W, Weina PJ, Mendez J, Reddy H, Goodrich R,. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light. Vox Sang 2006; 90: 85-91.
10. Goodrich RP, Edrich RA, Li J, Seghatchian J,. The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci 2006; 35: 5-17.
11. Cardo LJ, Salata J, Mendez J, Reddy H, Goodrich R,. Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfus Apher Sci 2007; 37: 131-137.
12. Rentas F, Harman R, Gomez C, Salata J, Childs J, Silva T, Lippert L, Montgomery J, Richards A, Chan C, Jiang J, Reddy H, Li J, Goodrich R,. Inactivation of Orientia tsutsugamushi in red blood cells, plasma, and platelets with riboflavin and light, as demonstrated in an animal model. Transfusion 2007; 47: 240-247.
13. Fast LD, Dileone G, Li J, Goodrich R,. Functional inactivation of white blood cells by Mirasol treatment. Transfusion 2006; 46: 642-648.
14. Babic AM,. Extracorporeal photopheresis: lighting the way to immunomodulation. Am J Hematol 2008; 83: 589-591.
15. Knobler R,. Extracorporeal photochemotherapy-present and future. Vox Sang 2000; 78 Suppl 2: 197-201.
16. Oliven A, Shechter Y,. Extracorporeal photopheresis: a review. Blood Rev 2001; 15: 103-108.
17. Russo GG, Mullen C,. Cutaneous and noncutaneous disorders treated with extracorporeal photopheresis. Int J Dermatol 2001; 40: 89-100.
18. Asano H, Lee CY, Fox-Talbot K, Koh CM, Erdinc MM, Marschner S, Keil S, Goodrich RP, Baldwin WM 3rd,. Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants. Transplantation 2007; 84: 1174-1182.
19. Kao KJ,. Induction of humoral immune tolerance to major histocompatibility complex antigens by transfusions of UVB-irradiated leukocytes. Blood 1996; 88: 4375-4382.
20. Kao KJ, Huang ES, Donahue S,. Characterization of immunologic tolerance induced by transfusion of UV-B-irradiated allogeneic mononuclear leukocytes. Blood 2001; 98: 1239-1245.
21. Drager UC, Hubel DH,. Studies of visual function and its decay in mice with hereditary retinal degeneration. J Comp Neurol 1978; 180: 85-114.
22. Sidman RL, Green MC,. Retinal degeneration in the mouse: location of the Rd locus in Linkage Group xvii. J Hered 1965; 56: 23-29.
23. Kao KJ,. Effects of leukocyte depletion and UVB irradiation on alloantigenicity of major histocompatibility complex antigens in platelet concentrates: a comparative study. Blood 1992; 80: 2931-2937.
24. Lamioni A, Carsetti R, Legato A, Landolfo A, Isacchi G, Emma F, Bottazzo GF, Dello Strologo L,. Induction of regulatory T cells after prophylactic treatment with photopheresis in renal transplant recipients. Transplantation 2007; 83: 1393-1396.
25. Lamioni A, Parisi F, Isacchi G, Giorda E, Di Cesare S, Landolfo A, Cenci F, Bottazzo GF, Carsetti R,. The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. Transplantation 2005; 79: 846-850.
26. Steinman RM, Turley S, Mellman I, Inaba K,. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000; 191: 411-416.
27. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N,. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000; 191: 423-434.
28. Gallucci S, Lolkema M, Matzinger P,. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999; 5: 1249-1255.
29. Huang FP, Platt N, Wykes M, Major JR, Powell TJ, Jenkins CD, MacPherson GG,. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med 2000; 191: 435-444.
30. Katzman SD, O'Gorman WE, Villarino AV, Gallo E, Friedman RS, Krummel MF, Nolan GP, Abbas AK,. Duration of antigen receptor signaling determines T-cell tolerance or activation. Proc Natl Acad Sci U S A 2010; 107: 18085-18090.
31. Marschner S, Fast LD, Baldwin WM 3rd, Slichter SJ, Goodrich RP,. White blood cell inactivation after treatment with riboflavin and ultraviolet light. Transfusion 2010; 50: 2489-2498.